{
    "metadataAttributes": {
    "title": "Pharmaceutical Preformulation and Formulation: A Practical Guide from Candidate Drug Selection to Commercial Dosage Form",
    "authors": "Mark Gibson",
    "keywords": "Pharmaceutical development, preformulation, formulation, drug selection, biopharmaceutics, drug delivery, dosage forms, stability testing, regulatory requirements",
    "description": "A practical guide covering pharmaceutical preformulation and formulation, from candidate drug selection to commercial dosage form development.",
    "publication_date": "2004",
    "categories": "Pharmaceutical Sciences, Drug Development, Formulation, Biopharmaceutics",
    "language": "English",
    "reference": "Library of Congress Card Number: 1-57491-120-1",
    "drug_development_stages": "Candidate drug selection, preformulation, early drug development, formulation, scale-up, commercial production",
    "dosage_forms_covered": "Oral, parenteral, inhalation, ophthalmic, nasal, topical, transdermal",
    "key_contributors": "Mark Gibson,Gerry Steele,Anna-Lena Ungell,Bertil Abrahamsson,Joanne Broadhead,Peter Davies,Nigel Day,Keith R. Brain,Kenneth A. Walters,Paul Wrigh",
    "publisher": "CRC Press LLC, Interpharm",
    "main_topics": "Drug discovery, candidate drug selection, preformulation studies, formulation development, biopharmaceutical considerations, regulatory environment, product optimization, stability testing, scale-up, commercialization"
    }
}